These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 19166259)

  • 41. The role of bioethics in the international prescription drug market: economics and global justice.
    Newland SE
    Penn Bioeth J; 2006; 2(2):8-12. PubMed ID: 17146900
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The corporate social responsibility of the pharmaceutical industry: idealism without illusion and realism without resignation.
    Leisinger KM
    Bus Ethics Q; 2005 Oct; 15(4):577-94. PubMed ID: 16358443
    [TBL] [Abstract][Full Text] [Related]  

  • 43. AIDS at Christmas time.
    Nature; 2005 Dec; 438(7071):1051. PubMed ID: 16371960
    [No Abstract]   [Full Text] [Related]  

  • 44. [Argentina, Brazil and Mexico. Biomedical research and the defense of a single standard of attention in developing countries].
    Angeles-Llerenas A; Bello MA; Dirce G; Salinas MA
    Rev Invest Clin; 2004; 56(5):675-85. PubMed ID: 15776872
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Biotechnology and the new politics of life and death in Brazil: the AIDS model.
    Biehl J
    Princet J Bioeth; 2002; 5():59-74. PubMed ID: 12755106
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The uneven impact of AIDS in a polarized society.
    Marais H
    AIDS; 2007 Jul; 21 Suppl 3():S21-9. PubMed ID: 17666958
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Health research, fair benefits and access to medicines.
    Lertsithichai P
    J Med Assoc Thai; 2006 Apr; 89(4):558-64. PubMed ID: 16696406
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Human rights responsibilities of pharmaceutical companies in relation to access to medicines.
    Lee JY; Hunt P
    J Law Med Ethics; 2012; 40(2):220-33. PubMed ID: 22789042
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [International collaboration among firms for the development of drugs for AIDS. An agreement among 15 pharmaceutical firms].
    Minerva Med; 1993; 84(7-8):XIV. PubMed ID: 8414128
    [No Abstract]   [Full Text] [Related]  

  • 50. Learning from practice: compulsory licensing cases and access to medicines.
    Stirner B; Thangaraj H
    Pharm Pat Anal; 2013 Mar; 2(2):195-213. PubMed ID: 24237026
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Do patents for antiretroviral drugs constrain access to AIDS treatment in Africa?
    Attaran A; Gillespie-White L
    JAMA; 2001 Oct; 286(15):1886-92. PubMed ID: 11597292
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Challenges of access to medicine and the responsibility of pharmaceutical companies: a legal perspective.
    Ahmadiani S; Nikfar S
    Daru; 2016 May; 24(1):13. PubMed ID: 27141958
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Early achievements of the Danish pharmaceutical industry--2. The minor and almost forgotten pharmaceutical companies].
    Grevsen JV; Kirkegaard H; Kruse E; Kruse PR
    Theriaca; 2009; (38):7-71. PubMed ID: 20027788
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [A proposal for the prevention of ethical problems related to drug promotion: a national network for drug information].
    Civaner M
    Turk Psikiyatri Derg; 2008; 19(3):310-7. PubMed ID: 18791884
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Medicines for the world: a way forward.
    James JS
    AIDS Treat News; 2004 Mar; (399):7-8. PubMed ID: 15199870
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [The role of the pharmaceutical industry. Why aren't new antibiotics being marketed?].
    García-Rey C
    Enferm Infecc Microbiol Clin; 2010 Nov; 28 Suppl 4():45-9. PubMed ID: 21458701
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Quality of medicines in least developed countries].
    Videau JY
    Med Trop (Mars); 2006 Dec; 66(6):533-7. PubMed ID: 17286015
    [TBL] [Abstract][Full Text] [Related]  

  • 58. "But doctors do it...": nurses' views of gifts and information from the pharmaceutical industry.
    Jutel A; Menkes DB
    Ann Pharmacother; 2009 Jun; 43(6):1057-63. PubMed ID: 19470854
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tackling corruption in the pharmaceutical systems worldwide with courage and conviction.
    Cohen JC; Mrazek M; Hawkins L
    Clin Pharmacol Ther; 2007 Mar; 81(3):445-9. PubMed ID: 17251983
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An ethical argument in support of interactions between developing world countries and pharmaceutical/biotechnology companies involved in oncology drug development.
    Markman M
    Cancer; 2008 May; 112(9):1871-3. PubMed ID: 18318430
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.